STOCK TITAN

Insider Form 144: 30,000-share option transaction for RVMD (RVMD)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mark A. Goldsmith provided notice under Form 144 of proposed transactions in common stock. The filing shows a prior sale of 15,394 common shares on 12/16/2025 for $1,182,525.52. It also lists a proposed transaction involving 30,000 common shares on 03/02/2026 tied to an exercise of stock options through Morgan Stanley Smith Barney LLC with $3,060,600.00 shown in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Form 144 reports proposed insider sales and an option exercise.

The filing lists a prior sale of 15,394 common shares on 12/16/2025 for $1,182,525.52, which is an executed transaction disclosed in the notice. The excerpt also lists a proposed 30,000-share sale on 03/02/2026 tied to an exercise of stock options.

Cash-flow treatment for the proposed transaction is shown as Cash and the broker-dealer named is Morgan Stanley Smith Barney LLC. Timing and final sale mechanics depend on transaction execution; subsequent filings may report completion.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Mark A. Goldsmith report in the Form 144 for RVMD?

He reported a prior sale of 15,394 shares and a proposed 30,000-share transaction. The filing shows a sale on 12/16/2025 for $1,182,525.52 and a proposed option-related transaction for $3,060,600.00 on 03/02/2026.

How many shares were sold by Mark A. Goldsmith on 12/16/2025?

15,394 common shares were sold on 12/16/2025. The excerpt lists the sale proceeds as $1,182,525.52, reflecting the reported transaction in the Form 144 notice.

What is the proposed 03/02/2026 transaction listed in the filing?

The filing lists a proposed transaction of 30,000 common shares on 03/02/2026 tied to an exercise of stock options. The broker-dealer named is Morgan Stanley Smith Barney LLC and $3,060,600.00 appears in the excerpt.

Who is the broker-dealer handling the proposed sale?

Morgan Stanley Smith Barney LLC is named in the excerpt as the broker-dealer. The filing line identifies Morgan Stanley Smith Barney LLC with the 30,000-share entry dated 03/02/2026.

Does the Form 144 confirm the 30,000-share sale was completed?

The excerpt lists the 30,000-share transaction as an exercise of stock options on 03/02/2026. The notice records the proposed transaction; completion and final sale reporting would appear in subsequent filings if executed.
Revolution Medicines, Inc.

NASDAQ:RVMD

RVMD Rankings

RVMD Latest News

RVMD Latest SEC Filings

RVMD Stock Data

19.65B
185.69M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
REDWOOD CITY